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Abstract 
Rationale: Cardiac lipotoxicity, characterized by increased 
uptake, oxidation and accumulation of lipid interme-
diates, contributes to cardiac dysfunction in obesity 
and diabetes. However, mechanisms linking lipid over-
load and mitochondrial dysfunction are incompletely 
understood. 
Objective: To elucidate the mechanisms for mitochon-
drial adaptations to lipid overload in postnatal hearts 
in vivo. 
Methods and Results: Using a transgenic mouse model of 
cardiac lipotoxicity overexpressing long-chain acyl-CoA 
synthetase 1 in cardiomyocytes, we show that mod-
estly increased myocardial fatty acid uptake leads to 
mitochondrial structural remodeling with significant 
reduction in minimum diameter. This is associated with 
increased palmitoyl-carnitine oxidation and increased 
reactive oxygen species (ROS) generation in isolated 
mitochondria. Mitochondrial morphological changes 
and elevated ROS generation are also observed in pal-
mitate-treated neonatal rat ventricular cardiomyocytes 
(NRVCs). Palmitate exposure to NRVCs initially acti-
vates mitochondrial respiration, coupled with increased 
mitochondrial membrane potential and adenosine tri-
phosphate (ATP) synthesis. However, long-term expo-
sure to palmitate (>8h) enhances ROS generation, 
which is accompanied by loss of the mitochondrial re-
ticulum and a pattern suggesting increased mitochon-
drial fission. Mechanistically, lipid-induced changes in 
mitochondrial redox status increased mitochondrial fis-
sion by increased ubiquitination of A-kinase anchor 
protein (AKAP121) leading to reduced phosphorylation 
of DRP1 at Ser637 and altered proteolytic processing 
of OPA1. Scavenging mitochondrial ROS restored mi-
tochondrial morphology in vivo and in vitro. 
Conclusions: Our results reveal a molecular mechanism by 
which lipid overload-induced mitochondrial ROS gen-
eration causes mitochondrial dysfunction by inducing 
post-translational modifications of mitochondrial pro-
teins that regulate mitochondrial dynamics. These find-
ings provide a novel mechanism for mitochondrial dys-
function in lipotoxic cardiomyopathy. 
Keywords: Cardiac lipotoxicity, mitochondrial dynamics, 
oxidative stress, heart failure, diabetic cardiomyopathy, 
metabolism, reactive oxygen species, lipids and cho-
lesterol, pathophysiology 
Nonstandard Abbreviations and Acronyms: 
4HNE  4-hydroxy-2-nonenal 
ACSL1  Long-chain acyl-CoA synthetase 1 
ACTA1  alpha skeletal muscle actin 
AKAP121  A-kinase anchor protein 121 
ATP  Adenosine triphosphate 
BNP  B-type natriuretic peptide 
BSA  Bovine serum albumin 
CDK1  Cyclin-dependent kinase 1 
CPT1  Carnitine palmitoyl transferase I 
DAG  Diacylglycerol 
DCFDA  2’,7’-dichlorofluorescein-diacetate 
DES1  Dihydroceramide desaturase 1 
DRP1  Dynamin related protein 1 
FA  Fatty acid 
IVS  Interventricular septum 
L4CL  Tetra-linoleic cardiolipin 
LCAD  Long-chain acyl-CoA dehydrogenase 
LVEDV  Left-ventricular end-diastolic volume 
LVEF  Left-ventricular ejection fraction 
MCAD  Medium-chain acyl-CoA dehydrogenase 
Mfn  Mitofusin 
NRVC  Neonatal rat ventricular cardiomyocyte 
OCR  Oxygen consumption rate 
OPA1  Optic atrophy 1 
OXPHOS  Oxidative phosphorylation 
PAGE  Polyacrylamide gel electrophoresis 
PPAR  Peroxisome proliferator-activated receptor 
ROS  Reactive oxygen species 
SOD2  Superoxide dismutase 2 
UPS  ubiquitin-proteasome system 
VDAC  Voltage-dependent anion channel 
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Introduction 
To maintain high energy requirements for contractile func-
tion, the heart requires an uninterrupted delivery of ox-
ygen and substrates that are oxidized to promote ade-
nosine triphosphate (ATP) synthesis. ATP consumption 
primarily fuels sarcomere contraction and ionic pumps 
that maintain membrane potential.1 In the healthy well-
oxygenated heart, mitochondria are central to cardiomyo-
cyte energy metabolism.1 Mitochondrial oxidation of fatty 
acids (FAs), glucose, ketone bodies and lactate accounts 
for the majority of ATP generation in cardiomyocytes. FAs 
derived from circulating triglyceride-rich lipoproteins and 
albumin bound non-esterified FAs are oxidized in the mi-
tochondrial matrix via β-oxidation, whereas pyruvate de-
rived from glucose and lactate is oxidized by the pyru-
vate-dehydrogenase complex, localized within the inner 
mitochondrial membrane. Acetyl-CoA formed from FAs 
and pyruvate is oxidized within the mitochondrial ma-
trix by the citric acid cycle. Healthy adult cardiomyocytes 
preferentially utilize fatty acids as an energy substrate.2-4 
However, energy substrate usage is flexible in normal 
hearts and varies to adapt to physiological or patholog-
ical stresses.5  
Diabetes and insulin resistance are the most common 
metabolic disorders in the world. Cardiovascular complica-
tions are the main cause of death from diabetes mellitus, 
given the high prevalence of comorbid risk factors, such as 
coronary artery disease. In addition, diabetes mellitus in-
creases the risk for heart failure by mechanisms that may 
be independent of underlying myocardial ischemia or hy-
pertension.6 This increased vulnerability termed “diabetic 
cardiomyopathy”, has a complex pathophysiology that in-
cludes altered myocardial substrate utilization.7, 8 An im-
portant characteristic of the metabolic abnormality in di-
abetic hearts is “metabolic inflexibility”, characterized by 
reduced glucose utilization and increased FA utilization. 
An imbalance between substrate uptake and utilization 
may lead to the accumulation of toxic metabolic interme-
diates.9 Studies by us and others reveal that, in addition 
to altered substrate utilization, diabetes or myocardial in-
sulin resistance impairs mitochondrial bioenergetics char-
acterized by decreased oxidative capacity, increased ROS 
generation and mitochondrial uncoupling.10-12 It is likely 
that mitochondrial dysfunction is multifactorial, although 
the relative contributions of increased lipid uptake versus 
changes in insulin signaling are incompletely understood. 
To understand the mechanisms by which increased 
cardiac lipid uptake could alter mitochondrial function, 
we investigated mice with cardiomyocyte-restricted low-
level overexpression of long chain acyl-CoA synthetase 1 
(ACSL1) in which myocardial palmitate biodistribution was 
moderately increased (2- fold).13 In this murine model, 
the modest increase in FA uptake dramatically remodeled 
the mitochondrial network, leading to the accumulation 
of elongated mitochondria with reduced diameter in car-
diomyocytes. Similar changes, appearing on 2-D micros-
copy as numerous “fragmented” mitochondria, were reca-
pitulated in rat neonatal cardiomyocytes (NRVCs) and L6 
myotubes following short-term exposure to the long chain 
FA palmitate. Mechanistically, these changes in mitochon-
drial morphology reflected changes in mitochondrial dy-
namics that were mediated via ROS-induced post-trans-
lational modification of mitochondrial proteins, AKAP121, 
DRP1 and OPA1. Thus, lipid overload leads to dysregula-
tion of mitochondrial dynamics, which may impair mito-
chondrial bioenergetics in diabetic cardiomyopathy. 
Methods 
The authors declare that all supporting data are avail-
able within the article and its supplementary materials. 
Detailed methods can be found in the supplementary 
materials. 
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Results 
Increased FA uptake elevates myocardial ceramide and 
diacylglycerol content and induces cardiac hypertrophy 
and modest systolic dysfunction. 
To investigate the consequences of persistent lipid over-
load in the heart, we examined mice with low-level over-
expression of long chain acyl-CoA synthetase 1 (ACSL1) 
driven by the cardiomyocytespecific α-MHC promoter 
(ACStg mice). Because our goal was to examine mitochon-
drial adaptations prior to the onset of lipotoxic cardiomy-
opathy, we studied the line with the lowest level of ACSL1 
overexpression, which does not develop overt heart failure 
until animals are 4-months old.13 Transgene expression 
was examined through development and ACSL1 protein 
was undetectable by Western blot in both wild-type (WT) 
and ACStg mice at birth (P0) despite ACSL1 mRNA expres-
sion being 13-fold greater in ACStg neonates compared 
to WT neonates (Fig. 1A, 1B). Increased ACSL1 protein in 
ACStg hearts was observed after P7 (Fig. 1A). Palmitate 
biodistribution measured by in vivo positron emission to-
mography (PET) at 12 weeks of age was increased 2-fold, 
indicating increased cardiac FA uptake in ACStg hearts 
(Fig. 1C). At this time point, there was no increase of myo-
cardial triglyceride content in ACStg hearts under random 
fed conditions (Fig. 1D). However, myocardial ceramide 
and diacylglycerol (DAG) content were significantly in-
creased in ACStg hearts (Fig. 1E, 1F). Consistent with the 
previous report, this moderate increase of lipid uptake 
induced a modest increase in ventricular weight to body 
weight ratio and ventricular wall thickness (IVS) on the 
basis of cardiomyocyte hypertrophy in ACStg hearts (Fig. 
1G-I, Supplemental Fig. I).13 Although there was no sta-
tistically discernable difference in LV end-diastolic volume 
(LVEDV) and LV ejection fraction (LVEF) measured by echo-
cardiography (Fig. 1J, K), cardiac catheterization revealed 
a significant reduction in arterial blood pressure in ACStg 
mice accompanied by decreased max dP/dt and min dP/
dt by the age of 24 weeks (Fig. 1L-N). Furthermore, BNP 
and alpha skeletal muscle actin (Acta1) expression were 
modestly increased in ACStg hearts by 2-fold (BNP) and 
1.3-fold (Acta1) at the age of 12 weeks (Fig. 1O). Taken to-
gether, a 2-fold increase of lipid uptake induces modest 
cardiac hypertrophy with preserved systolic function at 
the age of 12 weeks, but impairs systolic function at the 
age of 24 weeks. 
Figure 1: ACStg mice develop mild LVH with modest systolic dysfunction. (A) Representative western blot of Acsl1 protein ex-
pression in wild-type (WT) and Acsl1 transgenic mice (ACStg) from birth to 12- weeks of age. Numbers beneath each lane repre-
sents ACSL1 densitometry. The antibody recognizes both endogenous ACSL1 and the transgene. (B) mRNA expression of Acsl1 was 
quantified by RT-PCR at the age of P0 and 12-weeks. * P<0.05, ** P<0.01 vs. WT. (C) Representative PET image and quantification 
of 1-11C palmitate biodistribution in 12-wk-old WT and ACStg hearts; n =10-12. * P<0.05 (D-F) Cardiac triacylglycerol (D), ceramide 
(E), or diacylglycerol (F) content in 12-week-old WT and ACStg hearts; n =5. * P<0.05 vs. WT. (G) Quantification of ventricular weight 
(VW) vs body weight (BW) ratio. n =4 in each group. (H) Myocyte cross-sectional areas estimated from WGA-stained cross sections 
obtained from 24-wk-old ACStg mice and age-matched controls (n=2 hearts per genotype). See Supplemental Fig. I for represen-
tative image. (I-K) Echocardiographic analysis. Interventricular septal thickness (I), Left ventricle end-diastolic volume (LVEDV) (J), 
LV ejection fraction (LVEF) (K) , at 12 and 24-weeks of age. n= 5 at 12-weeks of age and n = 4 at 24-weeks of age. (L-M) Cardiac 
catheterization. Max dP/dt (L) and Min dP/dt (M) and arterial blood pressure (N) in ACStg hearts at 12 and 24-weeks of age. n =5 
at 12-weeks of age and n =4 at 24-weeks of age. (O) BNP and Acta1 mRNA expression were quantified by RT-PCR at 12- weeks of 
age. n =4, ** P < 0.01. All data are mean±sem. 
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Increased respiration and ROS production in isolated mi-
tochondria from ACStg hearts. 
In ACStg mice, oxygen consumption rates and ATP synthe-
sis rates in isolated mitochondria incubated with palmi-
toyl-carnitine as a substrate, were increased at 12-weeks 
of age, but were unchanged at 24-weeks of age relative 
to WT controls (Fig. 2A, 2B). In contrast, oxygen consump-
tion rates were not impaired with pyruvate or glutamate 
as substrates at 12- and 24-weeks of age respectively (Fig. 
2C, 2D). In addition, in-gel activities (in blue-native PAGE) 
of oxidative phosphorylation (OXPHOS) complexes I and 
IV were unchanged but complex V activity was increased 
at 12-weeks of age in ACStg hearts (Fig. 2E-G). Mitochon-
drial superoxide production (measured as H2O2 release 
from mitochondria) was increased 2-fold in ACStg heart 
mitochondria exposed to succinate or palmitoyl-carnitine 
as a substrate, and was completely inhibited by addition 
of rotenone (Fig. 2H). Increased ROS was not observed 
when glutamate was used as a substrate (Supplemental 
Fig. II-A), suggesting that ROS production derives from 
reducing equivalents that are oxidized by complex II. Ox-
idation of 2’,7’-dichlorofluorescein-diacetate (DCFDA) was 
increased in whole cell extracts of ACStg hearts (Fig. 2I). 
Moreover, increased mitochondrial 4-hydroxy-2-nonenal 
(4HNE) adducts in ACStg mitochondrial proteins, a highly 
toxic aldehyde byproduct of lipid peroxidation caused by 
ROS production, also supports increased mitochondrial 
ROS production (Fig. 2J). However, activity of mitochon-
drial aconitase was not reduced, suggesting that there was 
no increase in oxidative stress in the mitochondrial matrix 
of ACStg hearts, potentially the result of increased SOD2 
content (Fig. 2K, Supplemental Fig. II-B). Thus, short-term 
low-level lipid overload does not initially impair mitochon-
drial oxidative capacity in the murine heart despite in-
creasing ROS generation. 
Figure 2: Mitochondrial respiratory function and ROS production in isolated mitochondria from ACStg hearts. (A,B) Max-
imal ADP-stimulated mitochondrial oxygen consumption (A) and ATP synthesis rates (B) in mitochondria isolated from 12- and 
24-week-old WT and ACStg hearts using palmitoylcarnitine as a substrate; n =4-5. * P<0.05 vs. WT. (C,D) Maximal ADP-stimulated 
mitochondrial oxygen consumption in saponin-permeabilized cardiac fibers of 12- and 24-week-old WT and ACStg hearts using py-
ruvate (C) or glutamate (D) as a substrate; n =6. (E-G) Electrophoretic separation of OXPHOS complexes by blue-native PAGE (E), 
representative images of in-gel activities of complexes I, IV, and V (F), and quantification of OXPHOS complex activities (G), mea-
sured in 12-week-old WT and ACStg hearts; n =4. *P<0.05 vs. WT. (H) H2O2 production with succinate as a substrate in mitochondria 
isolated from 12- or 24- week-old WT and ACStg hearts, or with palmitoyl-carnitine as a substrate in mitochondria from 12-week-
old WT and ACStg hearts, in the absence or presence of rotenone (Rot); n =3 at 12wks, n =6 at 24wks. *P<0.05 vs. WT. (I) Oxidation 
of DCFDA in whole tissue extracts of 24-week-old WT and ACStg hearts; n =5-6. *P<0.05 vs. WT. (J) Western blot for 4HNE protein 
adducts in mitochondrial protein isolated from WT and ACStg hearts. Numbers beneath each lane represent densitometry of 4HNE 
immunoreactivity of all bands in that lane. (K) Aconitase activity measured in mitochondria isolated from 12- or 24-week-old WT 
and ACStg hearts; n =3 at 12weeks, n =6 at 24weeks. All data are mean ± sem. 
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Postnatal increase in mitochondrial cross-sectional area 
is attenuated in lipid-overloaded cardiomyocytes. 
We next investigated mitochondrial morphology. During 
the early postnatal period, cardiomyocytes dynamically 
change their structure and function to adapt to the in-
creased workload and oxygen consumption that paral-
lels the switch of substrate utilization from glycolysis to 
mitochondrial fatty acid oxidation.3 Mitochondrial mor-
phology also changes and volume density increases as 
they become larger and more ovoid in shape.14 2-D Elec-
tron microscopy revealed that mitochondrial dimension 
in WT hearts increased 2-fold within the first 3 weeks af-
ter birth before plateauing (Fig. 3A, Supplemental Fig. III-
A). This postnatal mitochondrial enlargement was absent 
in ACStg mice (Fig. 3A, Supplemental Fig. IIIA). In con-
trast, mitochondrial volume density was significantly in-
creased in ACStg hearts (Fig. 3A, 3B, Supplemental Fig. 
III-B, III-C), based upon the appearance of accumulated 
small mitochondria. To evaluate mitochondrial morphol-
ogy more precisely, we performed 3D-transmission elec-
tron microscopic tomography at the age of 8 weeks. 3D 
mitochondrial images revealed the presence of narrow but 
elongated mitochondria whose tortuous shapes crossed 
individual sectioning planes more than once (Fig. 3B, 3C). 
This is associated with an increase in number of cytosol-
mitochondrial membrane transitions on any projection 
between the Mlines of neighboring myofilament bundles 
(Fig. 3D) The short axis diameter of mitochondria was sig-
nificantly reduced in ACStg hearts by 60% (Fig. 3E). Taken 
together, perinatal lipid overload significantly alters age-
dependent structural mitochondrial remodeling, charac-
terized by a reduction in minimum diameter and morpho-
logical changes that are consistent with fragmentation of 
the mitochondrial network. 
These morphological changes could also reflect in-
creased biogenesis or altered dynamics of the mitochondrial 
network. To address this, we examined mRNA expression 
levels of peroxisome proliferator-activated receptor γ co-
activators 1 α/β (PGC-1α/β) and their targets, but found no 
evidence for increased mitochondrial biogenesis signaling 
(Fig. 3F). Thus, we hypothesized that lipid overload may alter 
signaling pathways that regulate mitochondrial dynamics. 
Mitochondrial dynamics is regulated by the activ-
ity of the dynamin superfamily of large GTPases, specifi-
cally mitofusin 1 and 2 (Mfn1 and Mfn2), optic atrophy 1 
(Opa1), and dynamin related protein 1 (DRP1).15,16 Mito-
chondrial fusion is mediated by OPA1 and Mfn1/2 which 
reside on mitochondrial inner and outer membranes re-
spectively. Fission is controlled by the cytosolic protein 
DRP1 that translocates from the cytosol to mitochondrial 
membranes following post-translational modifications to 
interact with the outer mitochondrial membrane protein 
Fis1. We determined the protein levels of these mitochon-
drial fusion and fission proteins and DRP1 phosphoryla-
tion during postnatal cardiac growth. Western blot anal-
ysis of whole heart lysates from wild-type mice revealed 
that DRP1 phosphorylation dramatically changed during 
the first 3 weeks of life (Fig. 3G, Supplemental Fig. IV-A). 
Consistent with increased postnatal mitochondrial dimen-
sions (fusion), DRP1 phosphorylation at S616, which acti-
vates DRP1-mediated mitochondrial fission, declined with 
age. In contrast, DRP1 phosphorylation at S637, which in-
duces mitochondrial fusion by inhibiting DRP1-mediated 
mitochondrial fission, increased over time (Fig. 3G, Sup-
plemental Fig. IV-A). This developmental increase in DRP1 
S637 phosphorylation was not observed in ACStg mice 
(Fig. 3H, Supplemental Fig. IV-B). These data suggest that 
cardiac lipid overload impairs postnatal mitochondrial re-
modeling by modulating DRP1 phosphorylation. 
Figure 3: Mitochondrial fragmentation in ACStg hearts. (A) Postnatal mitochondrial enlargement was attenuated in ACStg hearts. 
Stereologic quantification of mitochondrial minimum diameter and volume density was performed at the ages as indicated in 2-D 
electron micrographs (EM) presented in Supplemental Fig. III-A. ; n =3-4. * P<0.05, ** P<0.01, *** P<0.001. (B) Representative elec-
tron micrographs of longitudinal sections of WT and ACStg cardiomyocytes at the age of 8weeks, 3 hearts per genotype. Scale bars 
indicate 200nM. (C-E) Representative electron tomographic micrographs and corresponding 3D models of the mitochondrial net-
work. Scale bars indicate 100nM (C). Number of mitochondrial outer membranes transitioned on a straight line trajectory between 
M-lines of two neighbouring myofilament bundles, counted in 22 (WT) and 26 (ACStg) electron tomograms (3 hearts per genotype) 
(D). Short axis diameter was measured in 132 (WT) and 290 (ACStg) mitochondria of 22 (WT) and 26 (ACStg) electron tomograms 
from 3 hearts per genotype; ** P <0.01(E). (F) Myocardial gene expression in 12- and 24-week-old WT and ACStg mice normalized 
to 16S RNA transcript levels. Values represent fold change in mRNA transcript levels relative to WT, which was assigned as 1 (dashed 
line), n=8 *; P<0.05 vs WT. (G) Western blot of whole heart lysates probed with antibodies as indicated at postnatal ages as shown. 
d=day, w=week. See also Supplemental Fig. IV-A. Each sample at 0d, 1w and 3w was isolated more than 3 times and immunoblot-
ted separately, and each sample at day1, 2w and 8w was repeated twice. A representative western blot is shown. (H) Western blot of 
whole heart lysates from WT and ACStg mice probed with antibodies as indicated and harvested at the ages shown. See also Sup-
plemental Fig. Ⅳ B. All data are mean ± sem. Each sample at day0, 1wk and 3wk was isolated more than 3times and immunoblot-
ted separately, and each sample at 2wk and 8wk was repeated twice. A representative western blot is shown. 
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Lipid overload alters ubiquitin-proteasome mediated 
AKAP121 degradation and OPA1 proteolysis. 
Protein kinase A (PKA) mediated DRP1 phosphorylation at 
S637 inhibits DRP1 localization to mitochondria and sub-
sequent mitochondrial fission.17 The mitochondrial local-
ization of PKA and its ability to phosphorylate DRP1 is 
mediated by ubiquitin-proteasome mediated degrada-
tion of A kinase anchoring protein 121 (AKAP121), which 
are mitochondrial outer membrane scaffold proteins.18-20 
We therefore examined whether AKAP121 protein con-
tent might be decreased in ACStg hearts. In 12-week-old 
ACStg mouse hearts, western blotting revealed that DRP1 
phosphorylation at S637 was significantly reduced and 
phosphorylation at S616 increased (Fig. 4A-C). In addi-
tion, AKAP121 expression was also siginificantly decreased 
in ACStg hearts relative to WT (Fig. 4A, 4D), which was 
not related to any difference in AKAP121 mRNA expres-
sion (Fig. 4E). Therefore we tested whether posttransla-
tional regulation by the ubiquitin-proteasome system 
(UPS) might increase AKAP121 degradation in the face of 
lipid overload. WT or ACStg mice were injected intraperi-
toneally with MG132 or DMSO and whole heart homoge-
nates were subjected to western blot analysis. The protea-
some inhibitor MG132 blocked the reduction of AKAP121 
protein content in ACStg mice, suggesting that AKAP121 
is degraded by the UPS pathway in response to lipid over-
load (Fig. 4F). AKAP121 is a target of the ubiquitin ligase 
Siah2 in the context of hypoxia.20 However, Siah2 mRNA 
expression was not increased in ACStg hearts (Fig. 4G). 
Taken together, lipid overload altered DRP1 phosphory-
lation by enhancing AKAP121 degradation which may be 
independent of the hypoxia-stimulated pathway.  
We also examined whether the mitochondrial fusion 
protein, OPA1, could be affected by lipid overload. There 
are at least 8 mRNA variants of OPA1 as a result of alter-
native splicing.21 Variants 1 and 7 are dominant variants 
in mammalian cells. In response to decreased mitochon-
drial membrane potential, OPA1 also undergoes proteo-
lytic cleavage which impairs its ability to induce mitochon-
drial fusion.22 Western blot analysis of heart mitochondrial 
protein showed 5 bands of OPA1; 2 fusion-competent lon-
gisoforms and the 3 fusion-incompetent short-isoforms 
generated by the proteolytic processing of the 2 long-iso-
forms (Fig. 4H). Consistent with enhanced mitochondrial 
network fragmentation in ACStg hearts, the ratio of short-
form to long-form was increased by 1.7-fold in ACStg 
hearts (Fig. 4H, 4I). Thus, these data support the hypoth-
esis that mitochondrial dynamics shifts towards enhanced 
mitochondrial fission by at least two distinct mechanisms. 
Figure 4: Differential post-translational modifications of DRP1 and OPA1 in ACStg mice. (A-D) Decreased protein content of 
AKAP121, and altered phosphorylation profile of DRP1. Whole heart lysates were subjected to western blot analysis (A) and densi-
tometric quantification of DRP1pS616 (B), DRP1pS637 (C) and AKAP121 (D), n =4. ** P <0.01, * P <0.05. (E) AKAP121 mRNA expres-
sion of 12-week-old WT and ACStg mice was determined by quantitative RT-PCR (n=4) (F) AKAP121 degradation is mediated by the 
Ubiquitin-Proteasome pathway in ACStg hearts. WT or ACStg mice were injected intraperitoneally twice with DMSO or MG132 (18hrs 
and 6hrs before euthanasia). Whole-heart lysates were subjected to western blot analysis. (G) Siah2 gene expression in 12-week-old 
WT and ACStg mouse hearts was determined by realtime-PCR. Values are normalized to GAPDH expression. n=4. (H & I) Increased 
OPA1 cleavage in ACStg hearts. Mitochondrial fractions were prepared from 12-week-old WT or ACStg hearts and subjected to west-
ern blot analysis. Each lane shows the sample from different animals. The top 2 bands correspond to non-cleaved isoforms of OPA1 
(long-form) and the bottom 3 bands correspond to cleaved isoforms of OPA1 (short-form) (H), quantitative densitometric analysis 
of OPA1 isoforms (I), n =4. * P<0.05 vs. WT. All data are mean ± sem. 
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Effect of long chain FA, palmitate and oleate on 
mitochondrial respiration and ROS production in rat 
neonatal cardiomyocytes. 
To more directly determine the mechanistic basis for the 
mitochondrial adaptation to lipid overload, we treated 
cultured rat neonatal cardiomyocytes (NRVCs) with free 
fatty acids (FFAs). Because saturated fatty acids are the 
main mediators of lipotoxicity,23, 24 we treated NRVCs with 
bovine serum albumin (BSA)-conjugated palmitic acid 
(C16:0) to mimic lipid overload in vivo, and compared 
them with cells treated with the non-saturated fatty acid, 
oleic acid (C18:1). Oxygen consumption of lipid-treated 
NRVCs was determined with the Seahorse XF24 flux an-
alyzer. Although short exposure to palmitate (<4h) in-
creased mitochondrial oxygen consumption rates (OCR) 
in NRVCs, continued exposure (>8h) reduced OCR (Fig. 
5A, 5B, Supplemental Fig. V-A, V-B). In contrast, oleate 
treatment did not alter mitochondrial OCR (Fig. 5A). To 
confirm that this increase of OCR is coupled to mitochon-
drial oxidative phosphorylation and ATP synthesis, we ex-
amined time course changes of mitochondrial membrane 
potential and ATP content after palmitate treatment. Con-
sistent with OCR, palmitate treatment initially increased 
mitochondrial membrane potential and ATP content, but 
these parameters declined after continued incubation for 
more than 12h (Fig. 5C, 5D). We also examined ROS pro-
duction of cardiomyocytes after palmitate or oleate treat-
ment. As expected, western blotting of 4HNE revealed that 
ROS production was increased after palmitate treatment 
(Fig. 5E). CellROX Green (ROS probe) also accumulated in 
the nucleus after 12hrs of palmitate treatment (Fig. 5F, 5G). 
In contrast, oleate treatment did not increase 4HNE accu-
mulation (Fig. 5E). Taken together, palmitate supplemen-
tation initially accelerates mitochondrial respiration that 
is coupled to ATP synthesis. However, continued exposure 
to palmitate induces mitochondrial respiratory failure, po-
tentially on the basis of ROS-induced injury. 
Figure 5: Mitochondrial metabolism and ROS production in rat neonatal cardiomyocytes following increasing duration of 
free fatty acids exposure. (A) Basal oxygen consumption rate (OCR) (assayed by the Seahorse XF24 system) in NRVCs incubated 
with BSA alone, palmitate-BSA (500μM) or oleate-BSA (500μM). ** P<0.01. (B) Time course analysis of OCR of NRVCs treated with 
palmitate-BSA. Increased basal OCR after short-term exposure to palmitate (3hr) and reduced basal OCR after long-term exposure 
(15hr) of palmitate. **P <0.01 . See also Supplemental Fig. V. (C) Time course analysis of ATP content in NRVCs after palmitate or 
oleate treatment. ** P<0.01 vs BSA # P<0.05, ## P<0.01. (D) Time course analysis of mitochondrial membrane potential after pal-
mitate or oleate treatment. Cardiomyocytes were stained with TMRM and Hoechst at indicated times and fluorescence intensity was 
assayed with a plate reader. The ratio of TMRM/Hoechst fluorescence are shown. n = 4, * P<0.05 vs BSA, # P<0.05. (E) Western blot 
for 4HNE protein adducts in NRVCs after palmitate or oleate treatment. (F & G) CellROX green staining in NRVCs after palmitate 
treatment. CellROX Green is a DNA dye, and upon oxidation, it binds to DNA. Representative confocal image (F) and fluorescence 
intensity was quantified (G). ** P<0.01 vs BSA. All data are mean±sem. Scale bars indicate 20μm. 
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Altered mitochondrial dynamics in response to lipid over-
load is mediated in part by post-translational modifica-
tion of DRP1. 
We next determined if mitochondrial dynamics is modu-
lated by fatty acids in NRVCs. To visualize the mitochon-
drial network, cardiomyocytes were stained with mito-
tracker in live cells or immunostained with an anti-Tom20 
antibody in fixed cells. The normal mitochondrial net-
work in NRVCs appeared as tubular mitochondria (Fig. 
6A, Supplemental Fig. VI-A). Palmitate supplementation 
changed mitochondrial morphology from a tubular to 
small rounded shape (Fig. 6A, 6B, Supplemental Fig. VI-A). 
Interestingly, these morphological changes were not ob-
served in oleate-treated cardiomyocytes (Fig. 6A, 6B). We 
examined DRP1 phosphorylation profiles in NRVCs after 
palmitate treatment. Similar to P0 hearts (Fig. 3G, 3H), we 
detected no phosphorylation at S637 in isolated NRVCs 
throughout the time course. Instead, palmitate treatment 
increased DRP1 phosphorylation at S616 in NRVCs (Fig. 
6C). Immunohistochemistry revealed DRP1 translocation 
from the cytosol to mitochondria in response to palmitate 
treatment (Fig. 6D). To validate that DRP1 mediates mi-
tochondrial network fragmentation in lipid overload, we 
examined the effect of DRP1K38E, a dominant negative 
mutant of DRP1.25 DRP1K38E overexpression prevented 
palmitateinduced mitochondrial network fragmentation in 
NRVCs (Fig. 6E, Supplemental Fig. VII A). Furthermore, the 
reduced mitochondrial cross-section area observed was 
partially reversed in ACStg mice that lacked one DRP1 al-
lele in cardiomyocytes (ACStg DRP1+/-) (Fig. 6F, Supple-
mental Fig. VII B-E). Taken together, palmitate exposure 
shifts mitochondrial dynamics towards fission and away 
from fusion, in part via a DRP1-mediated mechanism. 
Figure 6: DRP1 mediates mitochondrial fission after lipid overload. (A) Rat neonatal cardiomyocytes were stimulated with growth 
medium with or without 500μM palmitate or oleate. 12hrs after stimulation, cells were fixed with 4% paraformaldehyde and immu-
nostained with α-actinin (green), Tom20 (red) and DAPI (blue). Scale bars indicate 20μm. (B) Quantification of mitochondrial frag-
mentation presented in Figure 6A. More than 100 cells were counted to determine the percentage (%) of cells with fragmented mito-
chondria. n=3, **: P<0.01. (C) Increased phosphorylation of DRP1 at Ser616 after palmitate treatment. NRVCs were treated in growth 
medium with 500μM palmitate and cell lysates were harvested at the indicated times in hr. (D) NRVCs were treated in growth me-
dium with or without 500μM palmitate and subjected to immunohistochemistry for DRP1 (green) and Tom20 (red). Note that DRP1 
is co-localized with Tom20 after palmitate treatment. Scale bars indicate 20μm. (E) NRVCs were infected with AdGFP or Ad DRP1K38E 
and were treated in growth medium with 500μM palmitate. NRVCs were subjected to immunohistochemistry for α-actinin (green) 
and Tom20 (red). See also Supplemental Fig. VII-A. Scale bars indicate 20μm. (F) Representative electron micrographs of longitudi-
nal heart sections obtained from WT, DRP1+/-, ACStg, and ACStg × DRP1+/-. DRP1 knockdown partially rescued mitochondrial mor-
phology in ACStg hearts. See also Supplemental Fig. VII B-E. 
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Mitochondrial morphology reflects the balance of mi-
tochondrial fusion and fission. To directly evaluate if pal-
mitate exposure inhibits mitochondrial fusion leading to 
mitochondrial network fragmentation, we co-cultured L6 
myoblasts expressing either mitoGFP or mitoRFP and in-
duced cell fusion with polyethylene glycol (PEG). L6 myo-
blasts displayed mitochondrial network fragmentation 
which was evident after 3hrs of palmitate supplemen-
tation (Fig. 7A, 7B). Mitochondrial network fragmenta-
tion was further augmented when expression of ACSL1 
was increased following retroviral transduction (Supple-
mental Fig. VI-B). After the induction of cell fusion with 
PEG, fusion of GFP and RFP-labeled mitochondria was ev-
ident in cells treated with control media when imaged 8hr 
following PEG-induced cell fusion (Fig. 7C top). In con-
trast, mitochondrial fusion was not observed in the cells 
incubated with palmitate-supplemented medium (Fig. 7C 
middle). To determine if palmitate pre-exposure perma-
nently impacted mitochondrial fusion in L6 myoblasts, 
cells were pretreated with palmitate supplemented me-
dium for 3hr that disrupted the mitochondrial network 
and then the medium was replaced with normal growth 
medium. Mitochondria regained their tubular structure 
following removal of palmitate, and fusion of GFP and RFP 
mitochondrial populations was observed, suggesting that 
palmitate-induced defects in mitochondrial fusion are re-
versible (Fig. 7C bottom). 
Figure 7: Mitochondrial fusion in L6 myoblasts was impaired by palmitate exposure. (A) L6 myoblasts transfected with mi-
toRFP were incubated in growth medium with or without 500μM palmitate for 5h, and representative images are shown. (B) Cells 
were evaluated to quantify tubular or fragmented mitochondrial networks, and cells with fragmented mitochondria were expressed 
as percentage of all viewed cells, n=4 and 80 cells counted per group. ** P< 0.01 vs BSA. All data are mean±sem. (C) L6 myoblasts 
were transfected either with mitoRFP or mitoGFP, co-plated (25,000 cells each) on cover slips for 24h, and then cell fusion was in-
duced with polyethylene glycol (PEG). Cells were fused for 8h in regular growth medium with no palmitate (top row), 8h in growth 
medium with 500μM palmitate, following 3h pre-incubation with 500μM palmitate prior to PEG fusion (middle row), or 8h in the 
regular growth medium with no palmitate, following 3h pre-incubation with 500μM palmitate prior to PEG fusion (bottom row). 
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Contribution of mitochondrial ROS generation to FA-me-
diated mitochondrial fragmentation. 
In light of our observations of increased lipid-mediated 
ROS production in vivo and in vitro that correlated with 
mitochondrial network fragmentation, we tested the hy-
pothesis that elevated mitochondrial ROS production may 
initiate downstream signaling events to alter mitochon-
drial dynamics. Because mitochondrial superoxide dis-
mutase 2 (SOD2) mediates superoxide detoxification at 
a diffusion limiting rate in the mitochondrial matrix,26 we 
examined whether SOD2 overexpression could rescue al-
tered mitochondrial morphology in ACStg hearts. We gen-
erated a cardiac-specific double-transgenic mouse har-
boring SOD2 and ACSL1 transgenes (ACS × SOD2 mice). 
As expected, enhanced superoxide production and in-
creased 4HNE adducts observed in ACStg mitochondria 
were almost completely rescued by the overexpression of 
SOD2 (Fig. 8A, 8B, Supplemental Fig. VIII-A). Mitochon-
drial cross-sectional area and apparent number were nor-
malized in ACStg hearts by SOD2 overexpression (Fig. 8C, 
Supplemental Fig. VIII-B). Surprisingly, SOD2 overexpress-
ing cardiomyocytes with reduced ROS production, demon-
strated a 4-fold increase in mitochondrial cross-sectional 
area estimated from 2-D images, suggesting that mito-
chondrial ROS levels are inversely correlated with mito-
chondrial dimensions (Fig. 8A, 8C). 
Finally, we determined if altered DRP1 phosphoryla-
tion or changes in OPA1 processing in ACStg mice were 
prevented by SOD2 overexpression. Western blot analy-
sis showed that protein expression of AKAP121 and DRP1 
phosphorylation at S637 was increased and DRP1 phos-
phorylation at S616 was reduced by SOD2 overexpression 
(Fig. 8D, 8E). In addition, total levels of DRP1 normalized 
to VDAC, which were increased in ACStg hearts, were nor-
malized by SOD2 overexpression (Fig. 8F, 8H). Overexpres-
sion of ACSL1 enhanced OPA1 proteolysis to specifically 
increase short isoform-d formation (Fig. 8F, 8G). Relative 
to ACStg, in SOD2/ACS double transgenic mice there was 
a reduction in isoform-d and an increase in isoform-e (Fig. 
8F, 8G). In vitro, MnTBAP, the SOD mimetic and peroxyni-
trite scavenger, partially normalized palmitate-induced mi-
tochondrial network fragmentation in NRVCs (Fig. 8I, 8J). 
Taken together, these data indicate that mitochondrial re-
dox signaling regulates mitochondrial dynamics by post-
translational modulation of mitochondrial fusion and fis-
sion proteins.  
Figure 8: Mitochondrial superoxide dismutase (SOD2) overexpression partially rescued abnormal mitochondrial dynamics 
in ACStg mice. (A,B) Enhanced ROS production in ACStg hearts was rescued by SOD2 overexpression. H2O2 production was deter-
mined in isolated mitochondria from 12-week-old WT, SOD2tg, ACStg and SOD2 x ACS double tg hearts in the absence or presence 
of rotenone (A). Mitochondrial fractions were prepared from 12-week-old WT, SOD2tg, ACStg and SOD2 x ACS double transgenic 
hearts and subjected to western blot for 4HNE and quantified by densitometry (B), n =3-4 in each group. ** P <0.01. See also Sup-
plemental Fig. VIII-A (C) SOD2 overexpression partially rescued fragmented mitochondria in ACStg hearts. Representative electron 
micrographs from WT, SOD2tg, ACStg and SOD2 x ACS double tg mice. Bar indicates 1μm. See also Supplemental Fig. VIII-B. (D-H) 
SOD2 overexpression reversed altered phosphorylation pattern of Drp1 and processing of OPA in ACStg hearts. Mitochondrial frac-
tions were prepared from 12-week-old WT, SOD2tg, ACStg and SOD2 × ACS double tg hearts and subjected to western blot anal-
ysis for AKAP121 and total and phosphorylated Drp1at Ser637 and Ser616 and the distribution of OPA1 isoforms were quantified 
(F-H). n =3-4 in each group. * P<0.05, ** P<0.01 vs WT, # P<0.05 vs ACStg . (I, J) MnTBAP prevented palmitate-induced mitochon-
drial fragmentation in NRVCs. NRVCs were treated with or without 400μM MnTBAP, a SOD mimetic and peroxynitrite scavenger, and 
then stimulated with or without growth medium containing 500μM Palmitate. After 12h of stimulation, cells were fixed and stained 
with Tom20 antibody. Representative image from each group. (I) and quantification of the ratio of fragmented cells (J), n =3 in each 
group. ** P<0.01. Scale bars indicate 20μm.  
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Discussion 
Recent studies have suggested that impaired mitochon-
drial energetics may contribute to the increased risk of 
heart failure in type-2 diabetes.8 The pathophysiology of 
mitochondrial dysfunction in diabetes is complex and may 
include altered insulin signaling, glucotoxicity and lipo-
toxicity. Prior work from our group suggested that im-
paired myocardial insulin signaling could precipitate mi-
tochondrial dysfunction in the heart.11 Given the likelihood 
that lipotoxicity could have distinct effects on mitochon-
dria, the present study was designed to model increased 
myocardial lipid accumulation to a level that was similar 
in magnitude to that reported in animal models of obe-
sity and diabetes.27 We therefore utilized mice with car-
diomyocyte-specific low-level overexpression of ACSL1, 
which gradually developed myocardial dysfunction and 
recapitulated key observations in neonatal cardiomyo-
cytes that were incubated with palmitate. First, we ob-
served that lipid overload initially enhances mitochondrial 
respiration coupled to ATP synthesis. However, prolonged 
lipid overload enhanced mitochondrial ROS generation, 
which is followed by reduced mitochondrial respiration 
and ATP synthesis. Second, we observed differential met-
abolic fates of palmitate and oleate in NRVCs. Our data 
indicates that increased mitochondrial respiration after 
palmitate supplementation results in accumulation of mi-
tochondrial ROS and impaired mitochondrial energetics. 
Conversely, oleate supplementation did not increase mi-
tochondrial respiration or ROS production and did not 
precipitate mitochondrial impairment. Third, mitochon-
drial redox status might influence mitochondrial morphol-
ogy by modulating the post-translational modifications 
of proteins that regulate mitochondrial dynamics. Lipid 
overload increased AKAP121 ubiquitination, modulated 
DRP1 phosphorylation and altered OPA1 processing. Fu-
ture studies in models with inducible increases in myo-
cardial lipid uptake will be needed to determine if these 
mechanisms also alter mitochondrial dynamics and en-
ergetics in adult (postnatal) murine hearts. Prior studies 
from our laboratory showed altered mitochondrial mor-
phology in db/db diabetic mice or type-1 diabetic Akita 
mice, which was accompanied by enhanced mitochondrial 
ROS production.10, 28 A recent study also revealed that 
right atrial cardiomyocytes isolated from type-2 diabetic 
patients exhibit increased mitochondrial ROS production 
and impaired mitochondrial bioenergetics.29 Taken to-
gether, these observations suggest that the mechanism 
observed in the present study could be universally appli-
cable to the pathophysiology of mitochondrial dysfunc-
tion in lipotoxic cardiomyopathy associated with obesity 
or diabetes mellitus. 
Following uptake of FAs in cardiomyocytes, ACSLs im-
mediately catalyze FAs to Acyl-CoA esters, which enter a 
variety of lipid metabolic pathways such as FA oxidation, 
TG synthesis/storage, phospholipid metabolism, and de 
novo ceramide synthesis. Cardiac ACSL1 over expression 
in vivo increases mitochondrial ROS production and the 
content of reactive lipid metabolites. We used a genetic 
approach to modulate mitochondrial ROS production by 
overexpressing ACSL1, SOD2, or both and demonstrated 
that mitochondrial redox status correlates with mitochon-
drial morphology. In addition, mitochondrial redox status 
is also associated with processing of mitochondrial pro-
teins, such as OPA1 proteolysis, ubiquitin proteasome me-
diated degradation of AKAP121 and DRP1 phosphoryla-
tion at S637. DRP1 phosphorylation at S616, a target site 
for MAP kinases and CDK1,30-32 also correlated with mi-
tochondrial redox status and was recapitulated by in vi-
tro palmitate treatment of NRVCs. These data are also 
supported by a recent publication showing that the ROS 
modulator 1 (ROMO1), a mitochondrial protein, is a redox-
sensitive factor that regulates mitochondrial morphology 
by affecting OPA1 cleavage and oligomerization.33 
A recently described mechanism that may also in-
duce mitochondrial fission is hypoxia. Siah2, a RING fin-
ger ubiquitin ligase induced by hypoxia, mediates ubiq-
uitin-proteasome degradation of AKAP121. Subsequent 
reduction of PKA-dependent inhibitory phosphorylation 
of DRP1 is an important regulatory pathway for hypoxia 
induced mitochondrial fission.20 In ACStg hearts, we also 
observed substantial proteasome mediated degradation 
of AKAP121 and mitochondrial redox status was corre-
lated with AKAP121 protein levels and DRP1 phosphor-
ylation at S637. However, in contrast to hypoxia, Siah2 
mRNA induction was not observed in ACStg hearts (Fig. 
4G), suggesting that an alternative mechanism may link 
the AKAP121 and DRP1 pathways in cardiac lipid overload. 
Our data also reveals that substrate availability and mi-
tochondrial dynamics plays an important role in the de-
velopmental maturation of mitochondria in the perinatal 
period. In fetal cardiomyocytes, energy substrate utiliza-
tion mainly depends on lactate and glucose supplied from 
the maternal circulation. After birth, energy substrate uti-
lization shifts rapidly from lactate oxidation and glycoly-
sis to fatty acid oxidation in mitochondria, and cardiomy-
ocytes preferentially utilize fatty acid as an energy source 
throughout their life.2, 34 In this process, mitochondria un-
dergo profound remodeling in terms of shape and vol-
ume, which is accompanied by an increase in the activi-
ties of enzymes required for lipid oxidation, such as LCAD, 
MCAD, CPT1, and ACSL1.4, 35 The progressive post-natal 
increase in mitochondrial dimensions was absent in AC-
Stg heart, which showed a multitude of apparently small 
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mitochondria occupying a larger fractional cell volume 
than WT. 3-D EM tomographic reconstructions revealed 
a narrow, elongated and tortuous morphology of mito-
chondria that is principally different from WT and which 
would be sectioned multiple times in a single plane. Our 
novel imaging methodology underscores the challenges 
in estimating mitochondrial size and number from 2-D 
images and adds new insight into the structural adapta-
tions of mitochondria in the heart when signaling path-
ways that regulate mitochondrial dynamics are perturbed. 
The substantial increase of fatty acid availability in the 
perinatal circulation activates PPARα that drives fatty acid 
oxidation in mitochondria.36, 37 We show here that DRP1 
phosphorylation is rapidly modulated during post-natal 
cardiac development. Furthermore, forced lipid uptake 
in the early post-natal period alters the developmental 
changes in DRP1 phosphorylation and prevented phys-
iological and maturation-dependent mitochondrial fu-
sion. An indispensable role of DRP1 in perinatal cardiac 
development has been recently reported.38-40 Taken to-
gether, post translational modifications of DRP1 after 
birth, plays an important role in normal perinatal mito-
chondrial maturation. 
Along with the alteration of mitochondrial membrane 
dynamics, mitochondrial membrane lipid content was also 
affected in our cardiac lipid overload model. Although 
the detailed molecular mechanisms involved are incom-
pletely understood, the lipid composition of cristae mem-
brane, specifically cardiolipin and phospholipids, plays an 
important role in mitochondrial membrane fluidity, cris-
tae structure and oxidative phosphorylation.41 Consistent 
with an elevation of cardiac ceramide and DAG levels (Fig. 
1E, 1F), phospholipid composition and the side chain pat-
tern of cardiolipin were significantly altered in ACStg mi-
tochondrial membranes (Supplemental Fig. IX-A, IX-B). 
Interestingly, there was a significant reduction in tetralin-
oleic (18:2)4 cardiolipin (L4CL) (Supplemental Fig. IX-A). It 
is widely accepted that L4CL is the fully functional CL spe-
cies and the reduction of L4CL has been associated with 
diabetes, heart failure, ischemia reperfusion injury, all of 
which are associated with impaired mitochondrial func-
tion.42, 43 These changes are due in part to an important 
role for cardiolipin in mitochondrial supercomplex forma-
tion and cytochrome oxidase activity.44 Moreover, L4CL 
is thought to promote more efficient proton flow and as 
such the reduction observed in ACStg mice could account 
in part for the increased ROS generation. 
We also addressed the contribution of increased ce-
ramide content in altering mitochondrial morphology in 
our lipid overload model in vivo and vitro. Using myriocin, 
an inhibitor for serine-palmitoyl transferase, which cat-
alyzes the first step of de novo ceramide synthesis, we 
determined that the inhibition of de novo ceramide syn-
thesis exacerbated ROS production in palmitate treated 
NRVCs (Supplemental Fig. X-A–E). Furthermore, in vivo 
inhibition of ceramide synthesis by heterozygous dele-
tion of Des1, an enzyme that catalyzes de novo ceramide 
synthesis, failed to reverse the altered mitochondrial net-
work (Supplemental Fig. X-F). These data indicate that in-
creased ROS resulting from mitochondrial lipid oxida-
tion likely represents a primary mechanism responsible 
for augmenting mitochondrial fission in lipid overload, 
and that ceramide accumulation does not contribute to 
this process. 
In summary, we demonstrate here that increased myo-
cardial lipid uptake impairs mitochondrial dynamics by 
increasing mitochondrial ROS generation, which modu-
lates post-translational modification of OPA1 and DRP1 
(Supplemental Fig. XI). We also provide evidence that mi-
tochondrial dynamics is involved in perinatal mitochon-
drial maturation and forced lipid uptake interferes with 
that process. These findings add a new dimension to un-
derstanding the regulation of mitochondrial morphology 
and physiology in the heart and its dysregulation by lipid 
excess. 
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Novelty and Significance 
What Is Known? 
●  Obesity and diabetes induce myocardial lipotoxicity 
that may reduce cardiac function. 
●  Cardiac lipotoxicity is associated with mitochondrial 
dysfunction including decreased oxidative phosphor-
ylation via incompletely understood mechanisms. 
What New Information Does This Article Contribute? 
●  Myocardial lipid overload by saturated fatty acids (FA) 
transiently increases mitochondrial respiration, mem-
brane potential and ROS production. 
●  FA-induced mitochondrial ROS overproduction induces 
post-translational modifications of mitochondrial fu-
sion/fission regulatory proteins that precipitate in-
creased mitochondrial fission. 
●   3D-electron tomography revealed that lipid overload 
in post-natal hearts induces ROS-mediated fragmen-
tation of the mitochondrial network, characterized by 
narrow tortuous and tubular morphology. 
Obesity, insulin resistance and diabetes are associated 
with increased fatty acids (FAs) utilization and reduced 
glucose utilization. One proposed mechanism for cardiac 
dysfunction called “lipotoxicity” is excess intracellular lipid 
accumulation secondary to a mismatch between lipid sup-
ply and utilization. In this study, using a mouse model 
with increased myocardial lipid uptake, we demonstrate 
that myocardial lipid overload induces mitochondrial ROS 
production, which alters the activity of DRP1 and OPA1, 
leading to fragmentation of the mitochondrial network 
characterized by a narrow tubular morphology. Thus, dys-
regulation of mitochondrial dynamics following lipid over-
load may represent an important mechanism contributing 
to mitochondrial and contractile dysfunction in lipotoxic 
cardiomyopathies.  
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Supplemental Materials   
Methods  
Animal model  
Mice with cardiomyocyte-restricted low-level overexpres-
sion of long-chain acyl- CoA synthetase 1 (ACStg) and 
control littermates (WT) were originally on the FVB back-
ground1. We prepared a transgenic line on the C57BL6j 
background by backcrossing more than 8 generations. 
DRP1 floxed mice (Kind gift of Hiromi Sesaki, Johns Hop-
kins University, Baltimore MD) were used to generate car-
diomyocyte-restricted heterozygous deletions of DRP1 
(Mixed Background). Sod2 transgenic mice (FVB back-
ground) were a kind gift from Paul Epstein (University of 
Louisville, Louisville, KY) and Des1 +/- mice (C57BL6 back-
ground) were a kind gift of Scott Summers (University of 
Utah, Salt Lake City, UT). Animals were studied in accor-
dance with protocols approved by the Institutional Ani-
mal Care and Use Committees of the University Utah and 
the Carver College of Medicine of the University of Iowa. 
All mice were housed at 22°C with free access to water 
and food (standard chow diet) with a light cycle of 12h 
light and 12h dark.   
In vivo cardiac function  
Echocardiography or left-ventricular (LV) catheterization 
was performed in a subset of the mice before respira-
tion studies as described previously.2 Mice were lightly 
anesthetized with isoflurane and imaged in the left lat-
eral decubitus position with a linear 13-MHz probe (Vivid 
V echocardiograph; GE Healthcare, Tampa, FL). Cardiac di-
mensions and function were calculated from these dig-
ital images. Invasive LV hemodynamic measurements 
were performed with a temperaturecalibrated 1.4-Fr mi-
cromanometer-tipped catheter (Millar Instruments, Hous-
ton, TX) inserted through the right carotid artery in mice 
anesthetized with choral hydrate (400 mg/kg) and ana-
lyzed as described by us previously.   
In vivo palmitate uptake  
In vivo palmitate uptake was measured by quantifying car-
diac palmitate biodistribution of 1-11C-palmitate using 
small-animal positron emission tomography (PET) as de-
scribed before.3   
In vivo MG132 administration  10mg of MG132 (EMD 
Millipore, Billerica, MA) was dissolved in Corn Oil (Sigma- 
Aldrich, St, Louis, MO) by rotating 24hrs in room tempera-
ture. MG132 (10mg/kg body weight) was administered in-
traperitoneally twice, prior to euthanasia (- 18h and - 6h). 
Cardiomyocyte isolation  
Primary cultures of neonatal rat ventricular cardiomy-
ocytes (NRVCs) were prepared from the ventricles of 
3-5-day-old Wistar rats as described previously.4 NRVCs 
were plated on type I collagen coated cover glass or cul-
ture plates and incubated with DMEM supplemented with 
BSA or palmitate-BSA. NRVCs were also infected with ad-
enovirus expressing either Ad-GFP or Ad-DRP1K38E at 10 
MOI. The CRP-DRP1-K38E adenovirus was a gift from Dr. 
Ruth Slack’s laboratory, Ottawa, Canada.5 After 12hr. of in-
fection, NRVCs were incubated in DMEM or palmitate as 
described above.   
Mitochondrial fusion assay  
Mitochondrial fusion was investigated using the PEG fu-
sion assay, as described before with minor modifications 
6. In brief, L6 myoblasts were infected with mitoGFP or mi-
toRFP (kind gifts from Dr. D. Chan) using retrovirus infec-
tion, and 25,000 cells expressing mitoGFP or mitoRFP were 
co-plated on 18mm coverslips in 6-well plates. Fusion was 
initiated by adding 300 μl of 50% PEG 1500 (Roche,  Indi-
anapolis, IN) for 60s, followed by addition of 2ml DMEM 
and two more washing steps with DMEM. Cells were incu-
bated with 1ml cycloheximide (30 μg/ml) for 8 h, washed 
with 1X PBS, and fixed with 3.7% formaldehyde. Cells were 
viewed on a FluoView FV1000 confocal microscope (Olym-
pus, Tokyo, Japan) at a magnification of 630x.   
Immunofluorescence  
Adult cardiomyocytes and neonatal rat ventricular car-
diomyocytes were isolated as described before.7 For mi-
tochondrial staining of adult cardiomyocytes, cells were 
incubated in HEPES buffer (126mM NaCl, 4.4mM KCl, 
1.0mM, MgCl2, 1.08mM CaCl2, 11mM dextrose, 0.5mM 
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probenecid, 24mM HEPES, pH 7.4) containing 100nM of 
the fluorescent potential-dependent indicator, tetrameth-
ylrhodamine ethyl ester (TMRE; Molecular Probes, Eu-
gene, OR), for 30min at 37°C. Cells were then placed into 
a glass-bottom perfusion chamber mounted on a Zeiss 
LSM 510 confocal microscope (Zeiss, Oberkochen, Ger-
many), perfused with HEPES-buffer at 37°C, and viewed. 
For neonatal rat ventricular cardiomyocytes grown on cov-
erslips, cells were washed in warm PBS, fixed in 4% para-
formaldehyde in PBS (15 min in room temperature), then 
washed in PBS, permeabilized with 0.2%TritonX in PBS (10 
min in room temperature) and blocked in blocking solu-
tion (5% BSA in PBS with 0.05% Tween20, 30 min in room 
temperature). Antibody labeling was performed by addi-
tion of 200 μl blocking solution with primary or secondary 
antibodies (1–5 μg/ml) and washing with PBS containing 
0.05% Tween20. Samples were mounted in 40% glycerol/
PBS on glass slides and sealed with clear nail polish. Im-
ages were acquired in an Olympus FV-1000 confocal mi-
croscope or a Zeiss LSM 710 confocal microscope. The fol-
lowing antibodies were used for immunohistochemistry: 
Tom20 (Santa Cruz Biotechnology, Dallas, TX, sc-11415), 
α-actinin (Sigma-Aldrich, A7811) and DRP1 (Novus Bio-
logicals, Littleton, CO, h00010059-m01).   
Mitochondrial function  
Mitochondrial oxygen consumption and ATP synthesis 
rates were measured in saponin permeabilized fibers us-
ing palmitoyl-carnitine/malate, pyruvate/malate, or glu-
tamate/malate as substrate combinations, as described 
before.8 Mitochondria were isolated by differential centrif-
ugation, and oxygen consumption and ATP synthesis were 
measured using palmitoyl-carnitine/malate, pyruvate/ma-
late, or glutamate/malate as substrate combinations, as 
described before.9 OXPHOS complexes of isolated mito-
chondrial membranes were separated by blue-native gel 
electrophoresis, and complex activities were determined 
by in-gel staining assays, as described before.9 Mitochon-
drial respiration rate in NRVCs were assessed using a Sea-
horse XFp Extracellular Flux Analyzer with the XFp Cell 
Mito Stress Test Kit (Agilent, Santa Clara, CA). In brief, 
NRVCs were plated at 75,000cells/well in a 24-well Sea-
horse assay plate and maintained for 48hrs with DMEM 
(5.5mM glucose, 10 μM AraC, 5% FBS and 10% horse se-
rum). 24hr before the assay, media was changed to DMEM 
(5.5mM glucose without AraC and serum) and subjected 
to Seahorse analysis with DMEM (5.5mM glucose) supple-
mented with BSA or fatty acid-conjugated BSA.   
Mitochondrial membrane potential assay  
Mitochondrial membrane potential in NRVCs was mea-
sured by TMRM fluorescence intensity. In brief, NRVCs 
were plated at 50,000 cells/well in a 96-well black bot-
tom dish. After palmitate stimulation, NRVCs were incu-
bated with 10 μM TMRM and 100μg/ml Hiechst for 30min 
at 37°C. TMRM (540/580) and Hoechst (360/450) fluo-
rescence intensity was measured by a SpectraMax3 plate 
reader (Molecular devices, Sunnyvale, California). The 
TMRM/Hoechst fluorescence ratio is used to determine 
the mitochondrial membrane potential.   
ATP extraction and quantification  
ATP content in NRVCs was measured by an ENLITEN ATP 
Assay System Bioluminescence Detection Kit for ATP Mea-
surement (Promega, Madison, WI). In brief, NRVCs were 
plated in a 96-well plate at a density of 50,000 cells/well. 
ATP was extracted with 50 μl of TCA (1%)/EDTA(4mM) 
buffer.   
Oxidative stress and superoxide production  
Mitochondrial H2O2 production was measured with a flu-
orometric assay as described before.8 Activity of aconitase 
was measured in isolated mitochondria using a spectro-
photometric assay, and tissue ROS levels were measured 
by the conversion of nonfluorescent 2’,7’-dichlorofluores-
cein-diacetate (DCFDA) to the highly fluorescent 2’,7’-di-
chlorofluorescein (DCF), as described before.8 In NRVCs, 
ROS levels were measured by CellRox Green reagent in 
accordance with the manufacturer’s instructions (Thermo 
Fisher Scientific, Waltham, MA).   
Quantification of mitochondrial dimension and vol-
ume density in 2D electron microscopy  
Samples for transmission electron microscopy were col-
lected from left ventricular myocardium and fixed in 2.5% 
glutaraldehyde/1% paraformaldehyde, post-fixed in 2% 
osmium tetroxide, embedded in resin, and sectioned (80-
100 nm thick), as described before.8 Mitochondrial vol-
ume density and dimensions of their two-dimensional 
(2D) cross-section were analyzed by 2D-stereology in a 
blinded fashion using the point counting method.8 Briefly, 
the image obtained at 3,000x magnification was overlayed 
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with square grids. Mitochondrial volume density was cal-
culated by a number of grids superimposed over mito-
chondria. Apparent mitochondria size was calculated as 
volume density / mitochondrial number.   
Electron microscopy and tomography  
Hearts were Langendorff-perfused with Tyrode’s solution 
containing 139mM NaCl, 3mM KCl, 17mM NaHCO3, 12mM 
D-(+)-glucose, 3mM CaCl2 and 1mM MgCl2 and cardiople-
gically arrested using a high-K+ (25 mM) no-Ca2+ mod-
ified Tyrode’s solution. Cardioplegically arrested hearts 
were perfusion-fixed with iso-osmotic Karnovsky’s fixa-
tive (2.4% sodium cacodylate, 0.75% paraformaldehyde, 
0.75% glutaraldehyde; 300 mOsm). Tissue fragments were 
excised from the left ventricle and washed with 0.1 M so-
dium cacodylate, post-fixed in 1% OsO4
 for 1 h, dehy-
drated in graded acetone, and embedded in Epon-Araldite 
resin. Thin (80 nm) and semi-thick (280 nm) sections were 
placed on formvar-coated slot-grids, post stained with 2% 
aqueous uranyl acetate and Reynold’s lead citrate. Colloi-
dal gold particles (15 nm) were added to both surfaces of 
the semi-thick sections to serve as fiducial markers for tilt-
series alignment. Preparations were imaged at the EMBL 
Heidelberg Electron Microscopy Core Facility using a Tec-
nai F30 electron microscope operating at 300 kV and Phil-
lips CM120 BioTwin electron microscope operating at 120 
kV. Images were captured on a 4K Eagle camera and SIS 
1K KeenView, respectively.  
For tomography, the SerialEM software package was used. 
The specimen holder was tilted from +60° to -60° at 1° 
intervals, followed by 90° rotation in the X-Y plane and 
a second round of acquisition (dual axis tilt). The images 
from each tilt-series were aligned by fiducial marker track-
ing and back-projected to generate two single full-thick-
ness reconstructed volumes (tomograms), which were 
then combined to generate a single high-resolution 3D 
reconstruction of the original partial cell volume. Isotro-
pic voxel size was 1.25 nm. All tomograms were processed 
and analysed using IMOD software, which was also used 
to generate 3D models of relevant structures of interest.10 
Immunoblot analysis  
Mitochondrial and cytosolic fractions were generated by 
homogenizing freshly excised hearts in homogenization 
buffer (20mM HEPES, 140mM KCl, 10mM EDTA, 5mM 
MgCl2, pH 7.4) with a Dounce tissue homogenizer, cen-
trifuging the homogenate at 800x g for 10min, and cen-
trifuging the resulting supernatant at 8,000 x g for 10min. 
The supernatant is the cytosolic fraction. The pellet was 
washed by centrifugation at 10,000 x g and represents the 
mitochondrial fraction. Whole-cell extracts and mitochon-
drial membranes were prepared as described before.11 
Samples were loaded on SDS-PAGE, transferred to nitro-
cellulose or PVDF membranes, and incubated with spe-
cific antibodies. Bands were visualized using horseradish 
peroxidase-conjugated secondary antibodies and the ECL 
detection system (GE Healthcare, Piscataway, NJ), or flu-
orophore-conjugated secondary antibodies and the Od-
yssey fluorescence detection system (Li-Cor Biosciences, 
Alpharetta, GA). The following antibodies were used for 
immunoblotting: ACSL1 (Cell Signaling Technology, Bos-
ton, MA, #4047), phospho- ERK1/2 (Cell Signaling Tech-
nology, #9101), phospho-SAPK/JNK (Cell Signaling Tech-
nology, #9251), DRP1 pS616 (Cell Signaling Technology, 
#3455), DRP1 pS637 (Cell Signaling Technology, #6319), 
DRP1 (Novus Biologicals, h00010059- m01), 4-Hydroxy-
neonal (4HNE) (Abcam, Cambridge, MA, ab46545), Mi-
tofusin 1 (Abcam, ab57602), OPA1 (BD Biosciences, San 
Jose, CA, #612606), Mitofusin 2 (Sigma-Aldrich, M6319), 
Fis1 (Enzo Life Sciences, Farmingdale, NY, ALX-210- 1037-
0100), MnSOD (Enzo Life Sciences, ADI-SOD-110-D).   
Cardiac mitochondrial lipid analysis  
For mass spectrometry sample preparation, tissue pieces 
were homogenized with a glass on glass homogenizer in 
PBS and lipids extracted according to a modified Bligh 
and Dyer method12, 13 using 1,000 nmol tetramyristal car-
diolipin as an internal standard (Avanti Polar Lipids). Car-
diolipin was quantified using our previously published 
methods12 using liquid chromatography coupled to elec-
trospray ionization mass spectrometry in an API 4000 
mass spectrometer.   
Statistical analysis  
Results are presented as means ± SEM. Data were ana-
lyzed using unpaired student T-tests. If more than two 
groups were compared, 1-way ANOVA was performed, 
and significance was assessed using Fisher’s protected 
least significance difference test. For T-tests and ANOVA, 
the Graphpad and Statplus software package was used 
(SAS Institute, Cary, NC). For all statistical analyses, signif-
icant difference was accepted when P < 0.05.
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Representative images of wheat germ agglutinin staining of transverse heart sections obtained 
from 24-week-old ACStg mice and age-matched controls. Myocyte cross-sectional area were 
FDOFXODWHGIURPWKHVHLPDJHVDQGSUHVHQWHGLQ)LJXUH+6FDOHEDUVLQGLFDWHȝP
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Supplemental Figure II








 production with glutamate or succinate as a substrate in mitochondria isolated from 12-week-old WT 
and ACStg hearts. n=3, *;P<0.05.vs.WT 
(B) Western blot of mitochondrial protein isolated from WT and ACStg hearts. Mitochondrial content of superox-
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(A) Representative electron micrographs of longitudinal (24 hours, 3 weeks) or transverse (vertical) sections of 
WT and ACStg hearts. Scale bars indicate 500nm.
(B) Representative confocal images of cardiomyocytes isolated from 12-week-old WT and ACStg hearts, loaded 
with TMRE for 30 min. Scale bars indicate 20ȝP
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(A) Quantification of western blot presented in Figure 3G. Postnatal change of DRP1 phosphorylation in 
Wild-type whole heart homogenates. 
(B) Quantification of western blot presented in Figure 3H. Postnatal change of DRP1 phophorylation was 
compared between Wild-type and ACS transgenic mouse hearts.
311307/R1Online Figure IV
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(A) Quantification of confocal images shown in Figure 6E. Mitochondrial aspect ratio was quantified by ImageJ as shown 
previously (Koopman et al., 2008). 
(B-C) Western blot images of DRP1 protein content in whole heart lysates of Wild-type (WT), DRP1+/- (DRP1ht), ACStg and 
compound mutant mice (B) and densitometric quantification of the immunoblot (C). 
(D-E) Stereologic quantification of mitochondria size (D) and volume density (E) in WT, DRP1ht, ACStg and ACStg x 
311307/R1































(A) Mitochondrial fractions were prepared from 12-week-old WT, SOD2tg, ACStg and SOD2 x ACS 
double transgenic hearts and subjected to western blot for 4HNE 
(B) Quantification of mitochondrial size obtained by blind counting of 2 equivalent sections from each of 
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(A) Cardiolipin composition in mitochondrial membranes isolated from 12 week-old WT and ACStg hearts 
measured by mass spectrometry (LC-MS/MS); n=6. 
(B) Content of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatydilserine (PS), and 
sphingomyelin (SM) in mitochondrial membranes of 12 week-old WT and ACStg hearts measured by thin-layer 
chromatography; n=6. 
Data in (A) and (B) are expressed as fold change relative to WT, which was set to 1 (dashed line). * p<0.05 vs. 
WT
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Ceramide
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De novo ceramide synthesis inhibition does not rescue mitochondrial fragmentation after lipid overload
(A) Lipids were extracted from NRVCs treated at the indicated time points after palmitate treatment and separated by thin 
layer chromatocraphy (TLC). Lipids were visualized with sulfuric acid spray. Lane 1 is C16-ceramide control and arrow 
indicates the position of ceramide. (B) Lipid was extracted from NRVCs by chloroform/methanol (2:1) and separated by 
TLC. Myriocin inhibited the increase in ceramide level after plamitate treatment. (C)  ROS production in NRVCs were 
visualised with CellROX green reagent (Thermo Fisher Scientific). ROS production was significantly increased after 
palmitate treatment. The blockade of ceramide de novo synthesis by myriocin enhanced ROS production. Scale bars indicate 
ȝP (D) The synthesis of 4-HNE protein adducts were enhanced in myriocin treated groups. (E) Mitochondria were 
immunostained with an anti-Tom20 antibody. Representative images of NRVCs incubated in culture medium supplemented 
ZLWK%6$RUȝ0SDOPLWDWHLQWKHSUHVHQFHRUDEVHQFHRIȝ0P\ULRFLQDQGTXDQWLILFDWLRQRIIUDJPHQWHGPLWRFKRQGULD
Scale bars indicate 20ȝP (F)5HSUHVHQWDWLYHHOHFWURQPLFURJUDSKVRIORQJLWXGLQDOVHFWLRQVIURPZHHNROGZLOGW\SH:7
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Myocardial lipid overload, by saturated fatty acids, transiently increases mitochondrial respiration and ATP 
generation. Prolonged exposure to lipids increases mitochondrial ROS that modifies Drp1 and OPA1 to 
impair mitochondrial dynamics and function in the heart, contributing to cardiac hypertrophy and 
dysfunction.
